SUBSCRIBE
SUBSCRIBE
News   Business

PhytoMedical Technologies, Inc. Announces Addition Of Proven Industry Executive; Drug Development And Commercialization Expert, James F. Lynch, PhD, MBA, Joins Scientific Advisory Board

September 6, 2006 | 
1 min read

PRINCETON, N.J.--(BUSINESS WIRE)--Sept. 6, 2006--PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6) today announced the addition of James F. Lynch, PhD, MBA, President of Strategic Access, Inc., to its Scientific Advisory Board.

People
MORE ON THIS TOPIC
cutting off a row of people into pieces
Layoffs
Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner
December 13, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff
December 12, 2024
 · 
205 min read
 · 
BioSpace Editorial Staff
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former CytoDyn Officials Found Guilty of Securities Fraud
December 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie